TCRT
Alaunos Therapeutics Inc
NASDAQ: TCRT · HEALTHCARE · BIOTECHNOLOGY
$2.55
-0.39% today
Updated 2026-04-30
Market cap
$6.16M
P/E ratio
—
P/S ratio
1,231.94x
EPS (TTM)
$-2.20
Dividend yield
—
52W range
$2 – $5
Volume
0.0M
Alaunos Therapeutics Inc (TCRT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-30,233.00%
ROE
-198.10%
ROA
-92.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-17.86M | — | — | — |
| 2007 | — | $-26.61M | — | — | — |
| 2008 | — | $-25.23M | — | — | — |
| 2009 | — | $-7.65M | — | — | — |
| 2010 | — | $-32.67M | — | — | — |
| 2011 | $667000.00 | $-63.78M | 100.00% | -10,704.65% | -9,561.92% |
| 2012 | $800000.00 | $-96.13M | 100.00% | -12,771.13% | -12,016.50% |
| 2013 | $800000.00 | $-57.11M | 100.00% | -7,214.13% | -7,138.38% |
| 2014 | $1.37M | $-31.78M | 100.00% | -3,168.17% | -2,314.71% |
| 2015 | $4.33M | $-120.09M | 100.00% | -2,772.39% | -2,772.11% |
| 2016 | $6.86M | $-165.30M | 100.00% | -2,409.37% | -2,409.23% |
| 2017 | $6.39M | $-54.32M | 100.00% | -837.27% | -850.26% |
| 2018 | $146000.00 | $-53.12M | 100.00% | -36,921.92% | -36,381.51% |
| 2019 | $0.00 | $-117.80M | — | — | — |
| 2020 | $0.00 | $-78.85M | — | — | — |
| 2021 | $398000.00 | $-78.75M | 100.00% | -19,484.67% | -19,786.68% |
| 2022 | $2.92M | $-37.73M | 100.00% | -1,201.40% | -1,291.24% |
| 2023 | $5000.00 | $-35.14M | -95,960.00% | -685,340.00% | -702,800.00% |
| 2024 | $10000.00 | $-4.68M | 100.00% | -48,120.00% | -46,790.00% |
| 2025 | $5000.00 | $-4.18M | 100.00% | -84,500.00% | -83,520.00% |